Benadryl For Sleep: Long-Term Risks To Brain Health

Taking diphenhydramine—the active ingredient in Benadryl and many PM pain relievers—for sleep produces drowsiness by dampening histamine-linked wakefulness, but that mechanism carries risks extending well beyond next-morning grogginess. Of particular concern is the drug’s anticholinergic activity: it blocks acetylcholine receptors, and acetylcholine production declines with age, meaning cumulative exposure carries increasing weight for midlife adults. A University of Washington study tracking roughly 3,500 adults over seven years found that three or more years of anticholinergic use was linked to approximately 54% higher dementia risk compared to three months or less.

Key findings from the research:

REM disruption: A controlled trial in healthy men found diphenhydramine extended REM latency to approximately 138 minutes (versus 100 minutes without the drug) and reduced REM as a proportion of total sleep to 16.2% (versus 20.5%)
Dementia association: Long-term use of three or more anticholinergic drugs together raised dementia incidence to roughly 2.5–2.6 times that of lower-exposure groups, per a 2023 analysis
Fall risk: A 2019 cohort of 10,698 older adults found certain combinations of moderate- and strong-potency anticholinergics were associated with approximately 2x fall and fall-injury risk
Tolerance and escalation: Regular use leads to diminishing sedative effect, prompting switches between diphenhydramine and doxylamine—patterns that increase cumulative anticholinergic burden
Acetylcholine and aging: Because acetylcholine production naturally declines with age, anything that further disrupts acetylcholine activity carries compounding relevance for adults in midlife and beyond

What Are the Long-Term Risks of Taking Benadryl for Sleep?

Diphenhydramine (Benadryl) is one of the widely used over-the-counter sleep aids, yet long-term nightly use carries risks that extend beyond next-day grogginess. The anticholinergic mechanism that produces drowsiness also affects acetylcholine — a neurotransmitter involved in memory, learning, and brain maintenance — with implications that accumulate over months and years of use.

I’ve been taking Benadryl every night for ~3 years now. It’s the only thing that knocks me out. Is it bad?”

This question appeared in my inbox recently, and variations of it come up often. The person mentioned some lingering grogginess in the morning, but otherwise assumed everything was fine.

If some version of that lives in your head, you are not the only one. Millions of adults use over-the-counter antihistamines as a regular sleep aid.

Subscribe now

The reasoning makes sense: it’s available without a prescription, it’s affordable, and it does produce sleepiness.

On the surface, it looks like a small trade: a familiar allergy ingredient, a predictable sedative effect, and side effects that look like “a little groggy” or “weird dreams.”

This article is about what sits underneath that trade:

The underappreciated risks that go beyond next-day drowsiness.
Why long-term use matters for brain health and dementia risk.
How these drugs disrupt your sleep architecture—even when they help you stay asleep.
How to think about your next step in a way that matches the complexity of your midlife physiology, instead of just asking, “What else can I take?”

Let’s get started.

How Do Over-the-Counter Sleep Aids Like Benadryl Work?

Common OTC sleep aids — including Benadryl (diphenhydramine), Unisom (doxylamine), and ZzzQuil — work by blocking histamine receptors in the brain, which reduces wakefulness. They cross into the brain and dampen histamine-linked alertness, but they also affect acetylcholine, coordination, and cognitive processing in ways that persist into the next day.

When someone says “I take Benadryl for sleep,” they are often referring to a cluster of products:

Benadryl, Advil PM, Tylenol PM, many store-brand “PM” pain relievers, and cold-and-flu combinations.

The sedating compound is typically diphenhydramine (Benadryl known) or doxylamine succinate, first-generation antihistamines originally developed for allergies and dermatitis.

What Are the Recognized Side Effects of Using Benadryl for Sleep?

When taken for sleep, antihistamines cross into the brain and dampen histamine-linked wakefulness — but the sedation comes with reduced coordination, slower reaction time, and impaired decision-making that can persist for 12+ hours after the dose. A next-day “hangover” feeling — grogginess, mental fog, dry mouth — is common and reflects the drug’s broad central nervous action rather than a sleep-specific effect.

When you take them for sleep, they:

Cross into the brain and dampen histamine-linked wakefulness.
Produce “knocked out” feeling.
Dry out mucous membranes (dry mouth, dry eyes).
Slow gut movement and make it harder to fully empty the bladder.

Many who use diphenhydramine regularly are familiar with these side effects. These are common enough that many users consider them acceptable trade-offs.

But, there is also a safety side.

How Does Benadryl Affect Reaction Time and Fall Risk in Older Adults?

Diphenhydramine impairs reaction time, coordination, and decision-making at levels comparable to alcohol intoxication. In older adults, this translates to increased fall risk — a U.S. National Transportation Safety Board report cited research showing next-day cognitive impairment from antihistamines contributed to motor vehicle incidents.

A U.S. National Transportation Safety Board (NTSB) report for a 2022 crash cited research showed that a single dose of diphenhydramine impaired driving ability more than a blood alcohol concentration of 0.10 g/dL—above the legal limit for drunk driving in many places.

The cognitive and motor impairment affects activities that require balance & coordination: driving, climbing stairs, getting up in the middle of the night to use the bathroom (through their effects on the vestibular system—independent of the drowsiness effects).

For adults in midlife and beyond, this translates into a higher fall risk. In a 2019 cohort of 10,698 older adults, higher anticholinergic burden from drugs such as diphenhydramine increased the hazard of a fall or fall-related injury, with certain combinations of moderate- and strong-potency anticholinergics having ~2x fall and fall-injury risk compared with lower-burden combinations.

Why Does Benadryl Stop Working Over Time?

With regular use, the body develops tolerance to diphenhydramine’s sedating effects. The initial dose that produced reliable drowsiness stops working at the same level, leading to dose escalation — a pattern that increases anticholinergic exposure without resolving the underlying sleep disruption.

With regular use, the body also develops tolerance to diphenhydramine’s effects. The initial dose that produced drowsiness becomes less effective over time, One pattern I’ve seen is some individuals will switch between diphenhydramine and doxylamine (Unisom SleepTabs and NyQuil) to “reset” the effect.

This pattern of tolerance and dose escalation matters because the risks scale with cumulative exposure, which brings us to the brain health consideration.

How Does Benadryl’s Anticholinergic Effect Relate to Brain Aging?

Diphenhydramine blocks acetylcholine receptors — the same neurotransmitter involved in memory formation, learning, and REM sleep regulation. The anticholinergic load from nightly use accumulates, and a University of Washington study tracking over 3,500 adults aged 65+ over 7 years found a dose-response association between cumulative anticholinergic exposure and dementia risk.

To understand why frequent use of over-the-counter older antihistamines raises concerns for long term brain health, we need to look at a different mechanism: anticholinergic activity.

What is acetylcholine, and what does it do?

Acetylcholine is a neurotransmitter with two main jobs.

In the brain, it plays a central role in learning, memory formation, and attention.
In the rest of the body, it stimulates muscle contractions and supports autonomic functions.

The body produces acetylcholine from choline, an essential nutrient found in eggs, liver, and other foods.

This is particularly relevant because acetylcholine production naturally declines with age, and the brain potentially becomes more sensitive to anything that further disrupts acetylcholine activity.

How Do Anticholinergic Drugs Affect Acetylcholine in the Brain?

Anticholinergic drugs block acetylcholine from binding to its receptors. Diphenhydramine and doxylamine both have strong anticholinergic properties, which means their effects extend beyond sedation into memory consolidation, attention, and the cholinergic pathways that regulate REM sleep architecture.

—by blocking acetylcholine from binding to its receptors.

Diphenhydramine and doxylamine both have anticholinergic activity, which is why it produces dry mouth, urinary retention, and constipation—these are all effects of blocking acetylcholine in the body.

They sit in the same broad category as tricyclic antidepressants, bladder medications used for urgency or overactivity, and certain drugs used in Parkinson’s disease.

The concern is not an isolated dose during a bad allergy flare.

The concern is cumulative anticholinergic burden:

How much exposure you build up over years across all your medications and over-the-counter products.

What Is the Association Between Long-Term Antihistamine Use and Dementia?

A University of Washington study followed over 3,500 adults aged 65 and older for approximately 7 years and found that higher cumulative anticholinergic exposure was associated with increased dementia risk. The relationship showed a dose-response pattern — more cumulative exposure correlated with higher risk.

A team from the University of Washington tracked ~3,500 adults ages >65 for ~7 years. The researchers documented all prescription and over-the-counter drugs each participant had taken in the 10 years before the study began.

During the follow-up period, ~800 participants developed dementia. When the researchers examined anticholinergic drug use, this is what they found:

People using anticholinergic drugs had higher dementia incidence than those not using them.
Taking an anticholinergic for the equivalent of ≥ 3 years was linked with ~54% higher dementia risk compared to taking the same dose for ≤ 3 months, even after accounting for other influences.

A 2023 analysis that focused on anticholinergic burden saw a similar pattern:

Long-term use of 1 anticholinergic drug increased dementia incidence roughly 1.5–1.6-fold.
Long-term use of 3+ anticholinergic drugs together increased dementia incidence to roughly 2.5–2.6-fold.

This does not mean, Benadryl alone causes dementia in any one individual.

It means that long-standing use of anticholinergic drugs—is an exposure your brain has to carry.

That exposure is something you can influence.

Adverse effects of diphenhydramine. Clark JH, et al. Diphenhydramine: It is time to say a final goodbye. World Allergy Organ J. 2025.

How Does Benadryl Disrupt Brain-Protective Sleep Architecture?

Sleep cycles through distinct stages, with each serving different physiological functions. Diphenhydramine suppresses REM sleep — the stage associated with memory consolidation and emotional processing — and can reduce deep slow-wave sleep, which is when the glymphatic clearance pathway removes waste proteins from the brain. Both effects undermine the brain-protective value of the sleep it produces.

Sleep cycles through distinct stages, with each stage serving different physiological functions. REM (rapid eye movement) sleep supports emotional processing, memory consolidation, and cognitive function.

Over time, chronic REM disruption may contribute to mood dysregulation, impaired memory, and reduced cognitive resilience.

A randomized trial in healthy men found those taking diphenhydramine:

had a longer delay before their first REM period (REM latency ~138 minutes versus ~100 minutes without the drug)
spent a smaller % of total sleep in REM (about 16.2% versus 20.5%).

This effect on REM is related to the anticholinergic mechanism discussed earlier. Acetylcholine is one of the neurotransmitters that promotes REM sleep. Blocking it with an anticholinergic drug suppresses REM.

This creates a situation where the drug produces unconsciousness but undermines the restorative properties of natural sleep.

Many people describe their antihistamine-assisted sleep as feeling drugged rather than truly rested. This makes sense given the mechanism. The drug suppresses wakefulness, but it also suppresses the natural sleep stages that produce the feeling of restoration.

In sum, when we zoom out, a Benadryl routine for sleep is doing three things at once:

Slowing reflexes and decision-making into the next day.
Adding to your anticholinergic burden over years.
Reshaping your REM sleep in a way that does not support long-term cognitive health.

That is very different from taking a targeted step to correct the physiology that drives your 2–4 a.m. wakeups.

How Should You Think About Sleep Problems Beyond “What Can I Take?”

When the approach starts with “what can I take tonight?” the investigation stays narrow — focused on overriding the wake-up rather than understanding what is producing it. Asking “what is my body doing at 3 a.m., and how can I support it more precisely?” opens a different set of variables: hormonal timing, metabolic stability, circadian alignment, and autonomic tone.

Some people do need ongoing treatment where these medications play a role.

If that is you, and the drug is medically important, consider sitting down with your clinician and ask whether another option exists for your situation, and whether your overall anticholinergic load can be reduced by adjusting other medications.

The rest of this section focuses on people who are using older antihistamines primarily as a sleep solution.

What Is a More Useful Question to Ask About Your Sleep?

Reframing from “what can I take?” to “what is my body doing at 3 a.m.?” changes the investigation. The first question leads to sedation. The second leads to understanding the hormonal, metabolic, circadian, or autonomic driver behind the disruption — and from there, to approaches that address the cause rather than overriding the experience.

The wellness loop offers another sleep gummy, another gadget, or a longer list of evening habits. Those can help at the margins. They do not address the more important question:

What is my body doing to produce this repeated sleep pattern, and how can I support that process in a way that matches midlife and later-life physiology?

Your body is not running a one-line script. Hormones, circadian timing, breathing, pain and metabolic factors all interact during your sleep window.

A single-target approach—whether that’s diphenhydramine, melatonin, or any other compound—can move one part of the process while the underlying physiology that drives the disruption stays intact.

This is why someone can take a sedating antihistamine for three years and still need it every night: it doesn’t address what’s creating the symptom.

A more foundational strategy starts with seeing the pattern and then organizing your next steps around root causes.

Subscribe now

What Are 6 Steps to Stop Taking Benadryl for Sleep and Address the Root Cause?

A framework for moving from nightly antihistamine use to root-cause investigation: describe your specific sleep pattern, connect it to daytime function, sort contributing factors into categories (hormonal, circadian, metabolic, stress), choose one to address over 4-6 weeks, decide how to learn and implement, and prepare for a different kind of medical conversation.

What follows is a framework for examining your own sleep pattern with more precision.

The goal is not to give you more tips (that may be marginally relevant to you) but to help you identify what your body is doing and focus your effort on the factors that matter most for your sleep recovery.

How Do You Describe Your Sleep Pattern With Enough Precision to Act On It?

For 7-10 days, record when you fall asleep, when you first wake up, and how long you remain awake. Note whether the wake-up feels wired or groggy, whether you can return to sleep, and what time you finally get up. This specificity reveals patterns that “I sleep badly” does not — and the pattern determines what to investigate.

For the next 7–10 days, record when you fall asleep, when you first wake up, and how long you remain awake during those waking periods. At the end of the tracking period, write a one-line label that captures the pattern.

Examples:

“5–6-hour ceiling with 3 a.m. wired wakeup”
“Easy onset but 2–4 a.m. restless window”
“Multiple 20-minute wakeups after 2 a.m.”
“Wake up energized”
“Wake up tired”, etc.

The point is to treat your sleep as having patterns. Patterns have causes.

How Does Your Sleep Pattern Show Up in Your Daytime Function?

Make a short list of how your specific sleep pattern affects your waking hours: slower thinking, more irritability, afternoon energy crashes, exercise recovery taking longer, or relying on caffeine past noon. Connecting sleep disruption to daytime consequences makes the cost visible and provides a baseline to measure improvement against.

Next, make a short list of how this exact pattern shows up when you are awake: slower thinking, more word-finding trouble, feeling less steady, needing more effort for ordinary tasks, feeling less confident driving or making decisions.

This moves the conversation from “I wish I slept longer” to “this pattern is affecting my independence, my cognition, and my daily function.”

That reframe matters for motivation and for how you prioritize the work ahead.

How Do You Identify What Is Driving Your Sleep Disruption?

Look at your pattern, your health history, and the last several years of your life, and ask which drivers are plausible: hormonal changes, circadian misalignment, metabolic instability, stress reactivity, or sleep-disordered breathing. More than one can be present. Narrowing to 1-2 primary candidates focuses the investigation rather than addressing everything at once.

Look at your pattern, your health history, and the last several years of your life, and ask which drivers sound most like you. Your sleep pattern is one set of clues. Your body and daytime function provide others—many of which run concurrent with sleep changes to inform on the patterns that help you identify the cause of your sleep issues. They can include:

Men:

Reduced stress recovery, irritability, or feeling “wired but tired”—often linked to testosterone changes
Difficulty maintaining or gaining muscle mass despite consistent training and adequate protein
Longer recovery from workouts or reduced stamina
Increased midsection fat despite no big change in diet or movement
Lower drive, reduced confidence, or morning fatigue
Nighttime urination, influenced by testosterone changes
Hotter at night in the upper body with cooler hands and feet, sometimes tied to altered testosterone

Women:

Heightened stress reactivity or anxiety that escalates more easily—often linked to progesterone or estrogen changes.
Temperature dysregulation or night sweats.
Nighttime urination from urethral or bladder tissue changes linked to estrogen changes.
New joint stiffness or tendon aches on waking
Increased frequency of UTIs or irritation

Both:

Mood shifts, brain fog, or motivation changes that appeared alongside sleep disruption.
Circadian disruption from screens and irregular schedules.
Pain or physical discomfort.
Snoring, reflux, coughing, or other breathing-related issues.
Blood sugar swings or late heavy meals.
Side effects from other medications that sedate or stimulate.

Most people can circle two or three that match their lived experience.

That is enough. You are moving from “I have bad sleep” to “I have a pattern driven by these specific factors.”

How Do You Choose Which Sleep Driver to Address First?

From the factors you identified, pick the one that feels central — the one that, if resolved, would likely improve the others. Hormonal changes and metabolic instability often reinforce each other, so addressing one can reduce the load on the other. A 4-6 week window is long enough to see whether the chosen approach is producing change.

From the factors you circled, pick the one that feels most central: hormone changes, circadian timing, breathing, pain, bladder, or metabolic factors. Commit to focusing on that area for the next four to six weeks.

That might mean an inflammation/pain-related project, a hormone-focused project, a circadian and light-timing project, or an assessment focused on breathing and oxygen during sleep.

This helps you move away from scattered tips and toward a targeted project that matches your pattern.

What Are Your Options for Implementing a Root-Cause Sleep Plan?

Once you can see your main driver and your questions, the choice is how to move forward: self-directed research and implementation, a structured program that provides the framework and decision tools, or a medical sleep evaluation with a provider who looks beyond standard screening. Each path has trade-offs in cost, time, and depth.

Once you can see your main driver and your questions, you face a choice in how to move forward.

One path is to assemble things yourself, reading and synthesizing peer reviewed articles.

The other path is to follow an organized educational roadmap built around your age range, hormone stage, and sleep pattern, with an order of operations. That kind of roadmap is how you translate root-cause thinking into day-by-day changes while you gradually dial back use of sedating products.

The key move is recognizing that long-term sustainable sleep recovery is a learning and implementation project.

How Do You Prepare for a Medical Visit That Goes Beyond Standard Sleep Screening?

Bring your 7-10 day sleep pattern log, your list of daytime consequences, and the root-cause categories you identified. Request specific labs relevant to your suspected driver (cortisol, fasting insulin, thyroid, sex hormones). This preparation changes the visit from a 15-minute checklist into a conversation grounded in your data.

If you opt for a medical sleep evaluation and solution, you can bring this to your clinician.

Bring your sleep-pattern name, a rough timeline of when it started, the drivers you identified, your one-sentence hypothesis, and the questions you wrote down.

Then the conversation can center on: “Here is what my sleep is doing and what I think is driving it. How do we investigate and support that?”

That’s a different conversation from: “What else can I take at night?”

Why Is Chronic Sleep Difficulty in Midlife a Regulatory Problem, Not a Sedation Problem?

For adults in midlife and beyond, chronic sleep difficulty tends to reflect something in the body’s regulatory processes — metabolic, hormonal, circadian, or autonomic — that needs attention. Over-the-counter sedatives mask that information. The alternative is not finding a safer sedative — it is identifying what the disruption is communicating and addressing it at the source.

OTC antihistamine (and other sedatives) mask that signal. The alternative is not finding a safer sedative.

It’s asking what your body is doing and building a strategy that respects the complexity of your physiology.

That’s a longer path.

It’s also the one that leads somewhere other than dependence on a drug that produce sedation at a cost.

It’s a path toward agency—independence not just from sedatives, but from the cycle of buying the next wellness product or waiting for the next appointment to tell you what to try.

That independence is what protects the life you’re building: the relationships, the hobbies, the energy to do the things you love.

Until next time,
—Kat

P.S. Write down three things you’d have more capacity for if you were living at 7–8 hours of sleep most days—hobbies, relationships, travel. That list matters more than your step counter.

If your pattern looks like 3 a.m. wakeups wrapped around slower recovery from workouts, harder time holding or building muscle, lower drive, feeling more revved up by stress, and more nighttime bathroom trips, you can look at the order of operations I use for that scenario here.

Reduce My 3am Wakeups, Naturally

References

Gray SL, Anderson ML, Dublin S, Hanlon JT, Hubbard R, Walker R, Yu O, Crane PK, Larson EB. Cumulative use of strong anticholinergics and incident dementia: a prospective cohort study. JAMA Intern Med. 2015 Mar;175(3):401-7. doi: 10.1001/jamainternmed.2014.7663. PMID: 25621434; PMCID: PMC4358759.
Poonawalla IB, Xu Y, Gaddy R, James A, Ruble M, Burns S, Dixon SW, Suehs BT. Anticholinergic exposure and its association with dementia/Alzheimer’s disease and mortality in older adults. BMC Geriatr. 2023 Jun 30;23(1):401. doi: 10.1186/s12877-023-04095-7. PMID: 37391728; PMCID: PMC10311860.
Green AR, Reifler LM, Bayliss EA, Weffald LA, Boyd CM. Drugs Contributing to Anticholinergic Burden and Risk of Fall or Fall-Related Injury among Older Adults with Mild Cognitive Impairment, Dementia and Multiple Chronic Conditions: A Retrospective Cohort Study. Drugs Aging. 2019 Mar;36(3):289-297. doi: 10.1007/s40266-018-00630-z. PMID: 30652263; PMCID: PMC6386184.
Weiler JM, Bloomfield JR, Woodworth GG, Grant AR, Layton TA, Brown TL, McKenzie DR, Baker TW, Watson GS. Effects of fexofenadine, diphenhydramine, and alcohol on driving performance. A randomized, placebo-controlled trial in the Iowa driving simulator. Ann Intern Med. 2000 Mar 7;132(5):354-63. doi: 10.7326/0003-4819-132-5-200003070-00004. PMID: 10691585.
Katayose Y, Aritake S, Kitamura S, Enomoto M, Hida A, Takahashi K, Mishima K. Carryover effect on next-day sleepiness and psychomotor performance of nighttime administered antihistaminic drugs: a randomized controlled trial. Hum Psychopharmacol. 2012 Jul;27(4):428-36. doi: 10.1002/hup.2244. PMID: 22806823.
Culpepper L, Wingertzahn MA. Over-the-Counter Agents for the Treatment of Occasional Disturbed Sleep or Transient Insomnia: A Systematic Review of Efficacy and Safety. Prim Care Companion CNS Disord. 2015 Dec 31;17(6):10.4088/PCC.15r01798. doi: 10.4088/PCC.15r01798. PMID: 27057416; PMCID: PMC4805417.
Clark JH, Meltzer EO, Naclerio RM. Diphenhydramine: It is time to say a final goodbye. World Allergy Organ J. 2025 Jan 25;18(2):101027. doi: 10.1016/j.waojou.2025.101027. PMID: 39925982; PMCID: PMC11803843.